Rate My Professor David Gracey

Gracey's research specializations center on the interaction between the immune system and renal disease, particularly in renal transplantation, transplant immunology, and kidney disease among patients with chronic viral infections such as HIV. He has authored key clinical guidelines, including the KHA-CARI guideline on recipient assessment for transplantation (Nephrology, 2013) and a consensus statement on renal monitoring for Australian patients receiving tenofovir-based antiviral therapy for HIV/HBV infection (AIDS Research and Therapy, 2014). Prominent publications include "Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV" (AIDS Research and Therapy, 2020, 107 citations), "Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection" (Antiviral Therapy, 2013, 94 citations), "Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial" (The Lancet, 2023, 80 citations), and "Outcomes of Dialysis Patients Living With HIV in Australia and New Zealand" (2025). With over 850 citations on Google Scholar and ResearchGate, his work has advanced understanding of nephrology in immunocompromised populations. Gracey chairs the NSW Transplant Advisory Committee, influencing transplant policy and practice. As a Clinical Professor, he contributes to medical education and training at the University of Sydney.